Patents by Inventor Jeffrey L. Nelson

Jeffrey L. Nelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers
    Patent number: 10064835
    Abstract: Disclosed is the combination of beta-hydroxy-beta-methylbutryate, arginine, and glutamine for use in a method of treating a diabetic ulcer in a diabetic individual having at least one of: (a) a serum albumin level of less than or equal to 4.0 g/dL, and/or (b) an Ankle-Brachial Index of less than 1.0. 9. Also disclosed is the use of the combination of beta-hydroxy-beta-methylbutryate, arginine, and glutamine for the manufacture of a medicament for use in the treatment of a diabetic ulcer in a diabetic individual having at least one of: (a) a serum albumin level of less than or equal to 4.0 g/dL, and/or (b) an Ankle-Brachial Index of less than 1.0. In certain embodiments, the combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine are orally administered via a nutritional composition.
    Type: Grant
    Filed: January 10, 2013
    Date of Patent: September 4, 2018
    Assignee: ABBOTT LABORATORIES
    Inventors: Jeffrey L. Nelson, Anne C. Voss, Maria G. Baggs, Charles L. Paule, Refaat A. Hegazi, Fabrizis Suarez, Gary Fanjiang
  • COMBINATION OF BETA-HYDROXY-BETA-METHYLBUTYRATE, ARGININE AND GLUTAMINE FOR USE IN TREATING DIABETIC ULCERS
    Publication number: 20150133548
    Abstract: Disclosed is the combination of beta-hydroxy-beta-methylbutryate, arginine, and glutamine for use in a method of treating a diabetic ulcer in a diabetic individual having at least one of: (a) a serum albumin level of less than or equal to 4.0 g/dL, and/or (b) an Ankle-Brachial Index of less than 1.0. 9. Also disclosed is the use of the combination of beta-hydroxy-beta-methylbutryate, arginine, and glutamine for the manufacture of a medicament for use in the treatment of a diabetic ulcer in a diabetic individual having at least one of: (a) a serum albumin level of less than or equal to 4.0 g/dL, and/or (b) an Ankle-Brachial Index of less than 1.0. In certain embodiments, the combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine are orally administered via a nutritional composition.
    Type: Application
    Filed: January 10, 2013
    Publication date: May 14, 2015
    Applicant: ABBOTT LABORATORIES
    Inventors: Jeffrey L. Nelson, Anne C. Voss, Maria G. Baggs, Charles L. Paule, Refaat A. Hegazi, Fabrizis Suarez, Gary Fanjiang
  • USE OF HMB TO IMPROVE HEALTH OUTCOMES FOR HOSPITALIZED PATIENTS
    Publication number: 20150119339
    Abstract: A method of care is described that includes administering an effective amount of ?-hydroxy-?-methylbutyrate (HMB) to an adult or elderly patient to decrease the risk of an adverse health event during or subsequent to hospitalization of the patient.
    Type: Application
    Filed: June 10, 2013
    Publication date: April 30, 2015
    Applicant: ABBOTT LABORATORIES
    Inventors: Menghua Luo, Jeffrey L. Nelson, Anne C. Voss, Owen J. Kelly, Geraldine E. Baggs, Min Tian, Jamie Partridge
  • Dry preparation of particulate solid energetic material
    Patent number: 5501132
    Abstract: Energetic material can be rapidly cut or machined at high speed in the substantial absence of liquid coolant with a cutting tool having a rotating cutting surface by maintaining a portion of the cutting surface out of contact with the energetic material and continuously removing the resulting reduced energetic material from the area of the cutting tool.
    Type: Grant
    Filed: August 31, 1994
    Date of Patent: March 26, 1996
    Assignees: Global Environmental Solutions, Inc., Hercules Incorporated
    Inventors: Clark C. de Nevers, Jeffrey L. Nelson, Steven T. Newsome, Patrick R. Oyler, Robert A. Patterson